XOMAP Q3 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$451,000-52.0% YoY

Gross Profit

$422,00093.6% margin

Operating Income

-$4M-969.4% margin

Net Income

-$4M-926.4% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-54.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$146M

Total Liabilities

$16M

Stockholders' Equity

$130M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$451,000	$940,000	-52.0%
Gross Profit	$422,000	$910,000	-53.6%
Operating Income	-$4M	-$3M	-30.7%
Net Income	-$4M	-$4M	+5.8%